Analysts Weigh in on Syneron Medical Ltd. (NASDAQ:ELOS)

Syneron Medical Ltd. (NASDAQ:ELOS) shares traded +1.29% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $9.00 within the next 52-weeks.  Since analyst price targets calculations are subjective, there often can be a wide range of targets from various analysts.  This is the consensus price target based on the analysts polled by Thomson Reuters’ First Call as of today’s date.  

Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. Syneron Medical Ltd. – Ordinary currently has a P/E Ratio of 90.23. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of 0.75.

Looking at stock performance, company shares have recently traded $0.33 away from the 50-day moving average of $7.52 and $0.69 away from the 200-day moving average of $7.16. The stock has been recently noted -7.32% off of the 52-week high of 8.47 and +28.48% off of the 52-week low of 6.11. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.